Thrilled to begin my new role as SoMe editor at #EHJCVI! Excited to help share the latest advancements in cardiovascular imaging research! Grateful to @EHJCVIEiC, @JGrapsa, and @EZancanaroMD for the trust and opportunity!

No longer a forgotten pathology, this important study just published in #EHJCVI demonstrates improvement in accuracy with corrected PISA values vs conventional method in assessment of TR severity: https://t.co/tc23Afmgk8 @denisamuraru @bogdan_popescu1 @EHJCVIEiC @pabloplopez_

#EHJCVI Does #midwall_LGE independently increase the risk of #MACE in patients with #nonischemic cardiomyopathy? Read more here: https://t.co/pTFr5JN296 @JGrapsa @EHJCVIEiC @pabloplopez_ @echo_stepbystep @saramoscatelli7 @AnnaKateBarton

#EHJIMP A 28-year-old female with a history of untreated #Kawasaki disease presents with #NSTEMI. Which imaging modality is #MOST useful for ongoing surveillance of coronary aneurysms in Kawasaki disease patients? https://t.co/13Qu9V5Djv @JGrapsa @alessia_gimelli @pabloplopez_

🎧 ¿Has escuchado ya el nuevo episodio del #podcast @raticosde100cia en el que el investigador @SanchoLab comenta cómo la #microbiota puede influir en la salud del corazón? 🧠🫀 El líder del laboratorio de #Inmunobiología del @CNIC_CARDIO explica cómo una molécula, el propionato

✅✅ A reminder by Dr. Rahaf Ajaj: She wasn’t on the Stanford list… but she made it to the Nobel stage. 🏅 Mary E. Brunkow, one of this year’s Nobel Prize winners in Medicine, has only 34 published papers and an H-index of 21. She never appeared in Stanford’s ranking of the

Please join us for annual Echo NY at Mount Sinai Hospital Practical talks and tips only, 8.25 CME Credits Registration link below https://t.co/cLGVHrXrqI @JGrapsa @LucySafi @KKoulogiannis

Honoured to be invited to #EchoNY2025 and looking forward to joining my friends @argulian Dr Stam Lerakis @KKoulogiannis @LucySafi - still time to register for a 360o overview of #echofirst ⬇️ @MassGenBrigham @BrighamWomens @MountSinaiNYC @IcahnMountSinai

Twice the spice: a unique association of hypertrophic cardiomyopathy and pericardial agenesis by @EHJCVIEiC Mónica Dias et al. ☑️ https://t.co/07d4qkUXbL A rare combo: 47-yo man with hypertrophic cardiomyopathy (#HCM) and partial congenital pericardial agenesis 🫀

Prognostic value of right ventricular longitudinal strain assessed by multimodal imaging in #amyloidosis : systematic review and meta-analysis by @EHJCVIEiC #Research Javier Herrera-Flores et al. https://t.co/6Nh74dMS7g @EACVIPresident @denisamuraru @lpbadano @donal @JGrapsa

It is also a great honour to see our work discussed in the excellent @EHJCVIEiC editorial by @benayozbay and @SadeLeylaElif🔗 https://t.co/BVaLQzCGz1 Thank you for this outstanding contribution to the discussion! 🙏 @arjunkg @Javihf_10 @keramidakallio3 @pedroluisSF @anguita_m

Team science at its best! 💪 So proud to share this comprehensive meta-analysis on the prognostic value of RV strain in #amyloidosis 📈 asssesed by multimodal imaging (echo/CMR). Honored as last author—thanks for the spotlight! https://t.co/UGSvh1bBY5 @EACVIPresident @EHJCVIEiC

How to approach assessment for ICD in patients with NICM? Really common clinical scenario, and so I was intrigued to read DERIVATE-NICM study and risk score just published in EHJCVI ✨ 🤩 @EACVIPresident @EHJCVIEiC @EHJIMPEiC @pabloplopez_ @carpenter_jp https://t.co/6MWY6Dyuu5

Mitral annular dysjunction-associated fibrosis on #WhyCMR 🩻 Learn how to spot scar in this condition in this excellent paper published in @EHJIMPEiC 🤩 1/4 patients with MAD = basal inferolateral scar @alessia_gimelli @VDelgadoGarcia @pabloplopez_ https://t.co/eUZqMPr4bw

Immunology takes center stage again at the #NobelPrize! Congratulations to Mary Brunkow, Fred Ramsdell & Shimon Sakaguchi for uncovering how regulatory T cells maintain immune tolerance—a discovery that transformed our understanding of autoimmunity and cancer immunotherapy

#EHJCVI🫀What’s the impact of VExUS in acute heart failure management and risk stratification?💧Improvement is linked to better mortality outcomes, while persistent abnormalities may require extended diuretic titration or closer monitoring 📖 Read more 👉 https://t.co/knbQjOCfXy

#EHJCVI🫀How can we better select NICM patients for ICD prevention therapy?⚡Does LGE provide additional prognostic value?🔍Midwall LGE and scar location significantly influence MAACE risk and can guide treatment decisions📖Read more 👉 https://t.co/rF396dNFUO #WhyCMR

Importance of basic science and research training for the future generation of #cardiologists 🫀Bridging the knowledge gap between #BasicScience and clinical #cardiology. 🫀 #Education is crucial to bridge the widening gap between discovery science and clinical science.

💔 #HFpEF is more than a heart issue—it’s a multisystem syndrome driven by inflammation, metabolism & organ crosstalk. Current drugs help some, but precision, multi-organ therapies are the future. Read that in #JCTR #CardioTwitter 👉 https://t.co/VDMbfTcMFI @ELaraPezzi #ISCTR

I'm honored to receive this award, which is really my lab @CNIC_CARDIO's award! Many thanks @BiophysicalSoc and all supporters I look forward to presenting our work on using #TEVp to study #protein #mechanics at #BPS2026 @SBEsp @academia_joven @SEBBM_es

Reliability of left ventricular global longitudinal strain across acquisition and analysis techniques: a prospective comparative study @VDelgadoGarcia @EZancanaroMD @saramoscatelli7 @JGrapsa @StefanoNistri